康恩贝 (600572)
Zhejiang Conba Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameZhejiang Conba Pharmaceutical Co., Ltd.
Listing Date2004-04-12
Issue Price8.25RMB
Registered Capital250645.827110k RMB
Legal RepresentativeYing Xujie
Registered AddressNo. 1 Conba Avenue, Lanxi City, Zhejiang Province
IndustryTraditional Chinese Medicine II
Main BusinessResearch, development, production, and sales of modern traditional Chinese medicine and natural botanical medicine products, with a focus on the R&D, production, and sales of drugs for the cardiovascular and cerebrovascular systems, urinary system, diabetes, and neuropsychiatric disorders.
Company ProfileZhejiang Conba Pharmaceutical Co., Ltd. is a pharmaceutical enterprise integrating R&D, production, and sales. The company is a national Torch Program key high-tech enterprise, one of the top 50 traditional Chinese medicine enterprises in China, a key backbone enterprise under Zhejiang Province's 'Five Batches' initiative, and a patent demonstration enterprise in Zhejiang Province. The company was listed on the Shanghai Stock Exchange in April 2004, stock code 600572, belonging to the pharmaceutical industry.
Stock Details
1. Key Indicators
- Total Shares(W): 252493.04
- Circulating A-Shares(W): 251818.85
- Earnings Per Share(RMB): 0.2320
- Net Assets Per Share(RMB): 2.7968
- Operating Revenue(W RMB): 497558.02
- Total Profit(W RMB): 69674.35
- **Net Profit Attributable to Parent(W RMB) **: 58403.47
- Net Profit Growth Rate(%): 12.65
- Weighted Return on Equity(%): 8.0500
- Operating Cash Flow Per Share(RMB): 0.2110
- Undistributed Profit Per Share(RMB): 1.4414
- Capital Reserve Per Share(RMB): 0.1025
2. Main Business
The main business covers:
- Drug research and development
- Manufacturing
- Wholesale and distribution business
3. Company Basic Information
- Company Name: Zhejiang CONBA Pharmaceutical Co., Ltd.
- Listing Date: 2004-04-12
- Industry: Pharmaceutical Manufacturing
- Address: No. 568 Binkang Road, Binjiang Science and Technology Economic Park, High-tech Development Zone, Hangzhou City, Zhejiang Province
- Website: www.conbapharm.com
- Company Profile: The company was established through the overall restructuring of Zhejiang CONBA Pharmaceutical Company, adopting a directional placement method in accordance with the "Standard Opinions on Joint Stock Companies." In May 1992 and August 1992, the Zhejiang Provincial Coordinating Group for Joint Stock Pilot Work approved with documents Zhe Gu [1992] No. 5 and Zhe Gu Mu [1992] No. 2, respectively. Zhejiang CONBA Pharmaceutical Company, jointly with Jinhua Trust and Investment Corporation, Zhejiang International Trust and Investment Corporation, and Zhejiang Phoenix Chemical Co., Ltd., acted as sponsors to restructure Zhejiang CONBA Pharmaceutical Company and establish Zhejiang CONBA Pharmaceutical Co., Ltd. through directional placement.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Pharmaceutical Health Industry Group Co., Ltd. | General Legal Person | 59420.97 | 23.60 |
| 2 | CONBA Group Co., Ltd. | General Legal Person | 25443.12 | 10.10 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 5073.91 | 2.01 |
| 4 | Zhejiang Dahua Investment Development Co., Ltd. | General Legal Person | 3887.66 | 1.54 |
| 5 | Southern China Securities 1000 Exchange Traded Open-End Index Securities Investment Fund | Fund | 1652.47 | 0.66 |
| 6 | ChinaAMC China Securities Traditional Chinese Medicine Exchange Traded Open-End Index Securities Investment Fund | Fund | 1128.85 | 0.45 |
| 7 | Boda Heyue Diversified Stable 30-Day Holding Bond型 Securities Investment Fund Class A | Fund | 1.80 | 0.00 |
5. Concept Sectors
- Vitamins
- Smart Healthcare
- Generic Drugs
- Industrial Hemp
- Medical Aesthetics Concept
- Helicobacter Pylori
- Innovative Drugs
Remarks
- Data update date: 2025-09-30
- Data source: Public market information